Type 2 Diabetes Trial, Recruiting (NCT06319703)

Type 2 Diabetes Trial, Recruiting NCT06319703 Sponsor: NYU Langone Health Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06319703 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who self-identify as a Chinese immigrant
People between 18 and 70 years old
People who have a diagnosis of Type 2 diabetes recorded in their medical records
People who have seen a doctor for routine Type 2 diabetes care within the past 12 months
People whose most recent HbA1c blood sugar measurement result is 8% or higher (confirm with trial site if unsure what this means for your situation)
People who are willing to receive short videos about managing Type 2 diabetes
People who own a smartphone, or who are willing and able to use a smartphone provided by the study

Who may not be able to join:

People who are unable or unwilling to give formal consent to participate
People who would have difficulty taking part in the program in a meaningful way, for example due to uncorrected vision or hearing problems
People who are unwilling to be randomly assigned to a study group
People who are currently pregnant, plan to become pregnant in the next 6 months, or become pregnant during the study
People who are currently breastfeeding, due to possible dietary restrictions involved in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lu Hu, PhD, NYU School of Medicine

Phone: 646-501-3438

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06319703

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 646-501-3438

More information: https://clinicaltrials.gov/study/NCT06319703

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who self-identify as a Chinese immigrant
People between 18 and 70 years old
People who have a diagnosis of Type 2 diabetes recorded in their medical records
People who have seen a doctor for routine Type 2 diabetes care within the past 12 months
People whose most recent HbA1c blood sugar measurement result is 8% or higher (confirm with trial site if unsure what this means for your situation)
People who are willing to receive short videos about managing Type 2 diabetes
People who own a smartphone, or who are willing and able to use a smartphone provided by the study

Who may not be able to join:

People who are unable or unwilling to give formal consent to participate
People who would have difficulty taking part in the program in a meaningful way, for example due to uncorrected vision or hearing problems
People who are unwilling to be randomly assigned to a study group
People who are currently pregnant, plan to become pregnant in the next 6 months, or become pregnant during the study
People who are currently breastfeeding, due to possible dietary restrictions involved in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

29 December 2024

Est. completion

31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Hemoglobin A1C (HbA1c) Test Scores; Change in Hemoglobin A1C (HbA1c) Test Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov